According to Anixa Biosciences's latest financial reports the company's total assets are $25.37 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-10-31 | $25.52 M | -16.08% |
2022-10-31 | $30.41 M | -16.12% |
2021-10-31 | $36.25 M | 283.55% |
2020-10-31 | $9.45 M | 50.2% |
2019-10-31 | $6.29 M | -2.4% |
2018-10-31 | $6.44 M | -26.82% |
2017-10-31 | $8.81 M | 56.58% |
2016-10-31 | $5.62 M | -39.71% |
2015-10-31 | $9.33 M | 3.09% |
2014-10-31 | $9.05 M | 66.47% |
2013-10-31 | $5.43 M | -3.91% |
2012-10-31 | $5.66 M | -34.53% |
2011-10-31 | $8.64 M | -13.94% |
2010-10-31 | $10.04 M | 2.01% |
2009-10-31 | $9.84 M | 31.35% |
2008-10-31 | $7.49 M | 300.92% |
2007-10-31 | $1.87 M | 0.35% |
2006-10-31 | $1.86 M | 27.1% |
2005-10-31 | $1.46 M | -36.69% |
2004-10-31 | $2.31 M | -0.62% |
2003-10-31 | $2.33 M | -14.68% |
2002-10-31 | $2.73 M | -58.38% |
2001-10-31 | $6.56 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 893.25% | ๐บ๐ธ USA |